ND646

ND-646 is an allosteric inhibitor of the ACC (Acetyl-coA carboxylase) enzymes that prevents ACC subunit dimerization to suppress fatty acid synthesis with IC50 of 3.5 nM and 4.1 nM for hACC1 and hACC2, respectively.

ND646 Chemical Structure

ND646 Chemical Structure

CAS: 1434639-57-2

Selleck's ND646 has been cited by 2 publications

Purity & Quality Control

Batch: Purity: 99.71%
99.71

ND646 Related Products

Choose Selective Acetyl-CoA carboxylase Inhibitors

Biological Activity

Description ND-646 is an allosteric inhibitor of the ACC (Acetyl-coA carboxylase) enzymes that prevents ACC subunit dimerization to suppress fatty acid synthesis with IC50 of 3.5 nM and 4.1 nM for hACC1 and hACC2, respectively.
Targets
hACC1 [1]
(Cell-free assay)
hACC2 [1]
(Cell-free assay)
3.5 nM 4.1 nM
In vitro
In vitro

ND-646 inhibits FASyn in vitro and induces apoptosis in NSCLC cells. AMPK phosphorylation sites can be used as a biomarker to monitor ACC engagement by ND-646.[1]

Cell Research Cell lines A549 cells
Concentrations 7 nM, 21 nM, 62 nM, 185 nM, 555 nM, 1666 nM, 5000 nM
Incubation Time 24 hrs
Method

All cell lines are incubated at 37 ℃ and are maintained in an atmosphere containing 5% CO2. A549, H460, H157 and H1355 cells are purchased from the ATCC. Cells are tested for Mycoplasma using manufacturer's conditions and are deemed negative. Cells are grown in Dulbecco's modified Eagles medium (DMEM) plus 10% fetal bovine serum. ACC1-KO clones are maintained in 10% FBS + addition of 200 μM palmitate every 3 days. For proliferation assays via cell counts, cells are plated into 24 well plates in triplicate at 2E4 cells/well and the following day treated with either DMSO vehicle or ND-646. Cell counts are recorded at days 1, 3, 5 and 7-post treatment. For delipidated media, cells are first seeded in media containing regular 10% FBS and the following day are switched into media containing 20% delipidated FBS upon treatment. Viability assays are performed using either a WST-1 viability assay or Cyquant in 96 well culture plates under manufacturers conditions. For quantitation, values from treated cells are divided by values from control treated cells and expressed as percent control. Palmitate rescue experiments are performed in delipidated media by co-treating cells, in 24 well plates, with ND-646 and 200 μM of palmitate conjugated to BSA. For palmitate-BSA preparation, palmitate is solubilized in 100% Etoh @ 50 mM and combined with 4% fatty acid free BSA in saline at a ratio of 1:4 to make a palmitate concentration of 10 mM. Palmitate-BSA is used at a final concentration of 200 μM.

In Vivo
In vivo

Chronic ND-646 treatment of xenograft and genetically engineered mouse models of NSCLC inhibits tumor growth. When administered as a single agent or in combination with the standard-of-care drug carboplatin, ND-646 markedly suppresses lung tumor growth in the Kras;Trp53−/− (also known as KRAS p53) and Kras;Stk11−/− (also known as KRAS Lkb1) mouse models of NSCLC.[1]

Animal Research Animal Models female athymic nude mice
Dosages 25 mg/kg, 50 mg/kg
Administration Oral gavage

Chemical Information & Solubility

Molecular Weight 568.64 Formula

C28H32N4O7S

 

CAS No. 1434639-57-2 SDF --
Smiles COC1=CC=CC=C1C(CN2C(=O)N(C(=O)C3=C2SC(=C3C)C4=NC=CO4)C(C)(C)C(N)=O)OC5CCOCC5
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

DMSO : 100 mg/mL ( (175.85 mM); Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 100 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy ND646 | ND646 supplier | purchase ND646 | ND646 cost | ND646 manufacturer | order ND646 | ND646 distributor